VRTX

Vertex Pharmaceuticals Incorporated $515.44 1M -2.0% 3M +15.8% YTD +14.0% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
+0.5%
Next 1 month
-1.1%
Seasonality
Weak window historically
Next 30 days (to Oct 13): -4.5% median, 32% of the last 34 years finished up.
20-year seasonality chart →
Mean reversion
Oversold — RSI(2) at 12
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.14%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.53 +0.1% · Seasonal tilt -1.2%
$133.0B market cap (#93 US) $549M/day volume 29% volatility +33% 1-year -8% from ATH
52-week range · 76% of the way up · -8% from the high
$374.17$560.25

Congressional trades in VRTX Full tracker →

17 members · 14 buys / 23 sells · $107K–$730K disclosed · latest filing Sep 5, 2026.

SELL DT David J. Taylor · traded Aug 26, 2026 $1K–$15K
SELL TT Thomas H Tuberville · traded May 3, 2024 $1K–$15K
BUY AA Alan Armstrong · traded Mar 27, 2026 $1K–$15K
SELL DT David J. Taylor · traded Jan 29, 2026 $1K–$15K
BUY JL Julia Letlow · traded Oct 23, 2024 $1K–$15K
BUY DT David J. Taylor · traded Aug 7, 2025 $1K–$15K
BUY LM Lisa McClain · traded Dec 11, 2024 $1K–$15K
SELL LM Lisa McClain · traded Jun 11, 2025 $1K–$15K

Earnings Full history →

Next report 2026-11-02 (Monday, after close, in 50 days) · EPS est. -1.74.

1-day std dev
4.7%
Finished up
47%
Biggest pop
+9.0%
Biggest drop
-20.6%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.